4//SEC Filing
Portnoy Mark L. 4
Accession 0000950170-25-008396
CIK 0000862692other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:00 PM ET
Size
15.3 KB
Accession
0000950170-25-008396
Insider Transaction Report
Form 4
Portnoy Mark L.
DirectorCo-CEO10% Owner
Transactions
- Award
Stock Option
2025-01-21$8.08/sh+25,000$202,000→ 25,000 totalExercise: $8.08From: 2025-01-21Exp: 2030-01-21→ Common Stock (25,000 underlying)
Holdings
- 20,000
Stock Option
Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (20,000 underlying) - 25,000
Stock Option
Exercise: $6.47From: 2023-12-22Exp: 2028-12-22→ Common Stock (25,000 underlying) - 42,266(indirect: By 401(k))
Common Stock
- 100,000
Stock Option
Exercise: $12.27From: 2021-12-22Exp: 2028-12-22→ Common Stock (100,000 underlying) - 71,529(indirect: By Partnership)
Common Stock
- 22,222
Stock Option
Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common stock (22,222 underlying) - 25,000
Stock Option
Exercise: $4.30From: 2022-12-23Exp: 2027-12-23→ Common Stock (25,000 underlying) - 821,973
Common Stock
- 25,000
Stock Option
Exercise: $4.77From: 2023-01-03Exp: 2028-01-03→ Common Stock (25,000 underlying)
Footnotes (5)
- [F1]Shares of common stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark Portnoy may be deemed beneficial owner as its general partner.
- [F2]Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
- [F3]8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
- [F4]Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
- [F5]Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.
Documents
Issuer
CRYO CELL INTERNATIONAL INC
CIK 0000862692
Entity typeother
Related Parties
1- filerCIK 0001529249
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:00 PM ET
- Size
- 15.3 KB